FDA Import Refusal AEK-4959489-6/11/1 — Laborate Pharmaceuticals India Ltd.
The FDA refused shipment AEK-4959489-6/11/1 from Laborate Pharmaceuticals India Ltd. (India) on Apr 11, 2024. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 11, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 75